A new cancer treatment combines conventional chemotherapy drugs with a digital sensor in a single capsule.
Developed by biotech company Proteus Digital Health, the “digital medicine solution” communicates with a patch worn on the patient’s body which sends data to the patient and clinical team through a smartphone app. With more patients taking oral chemotherapy drugs at home, the technology allows for easier tracking of patient adherence. So far the solution is only being used in a small cohort of patients, but may be expanded in the near future.
Click here to read more about the work from Proteus Digital Health.